GE Healthcare, Vanderbilt University Medical Center Partner for Safer, More Precise Immunotherapy Cancer Treatment
Summary
GE Healthcare, Vanderbilt University Medical Center partner for safer, more precise immunotherapy cancer treatment (Photo: Business Wire)GE Healthcare, Vanderbilt University Medical Center partner for safer, more precise immunotherapy cancer treatment (Photo: Business Wire)CHICAGO & NASHVILLE, Tenn.--( BUSINESS WIRE )--GE Healthcare and Vanderbilt University Medical Center (VUMC) today announced a five-year partnership to enable safer and more precise cancer immunotherapies.Multiple diagnostic tools will be developed to help predict both the efficacy of an immunotherapy treatment and its adverse effects for a specific patient before the therapy is administered.Simultaneously, GE Healthcare and VUMC will develop new positron-emission tomography (PET) imaging tracers, which together with the apps, will help physicians to stratify cancer patients for clinical trials.